155 related articles for article (PubMed ID: 37898858)
1. Genetic Polymorphism in FSCN1 rs3801004 C/G and CD44 rs353639 A/C, as Prognostic Factor in Egyptian Breast Cancer Patients.
Ibrahim NE; Raafat Hamed RM; Refaat A; Mosaad YO; Mekawy DM
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3517-3523. PubMed ID: 37898858
[TBL] [Abstract][Full Text] [Related]
2. FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer.
Wang CQ; Tang CH; Wang Y; Jin L; Wang Q; Li X; Hu GN; Huang BF; Zhao YM; Su CM
Sci Rep; 2017 Nov; 7(1):15887. PubMed ID: 29162880
[TBL] [Abstract][Full Text] [Related]
3. The association of FSCN1 (rs852479, rs1640233) and HOTAIR (rs920778) polymorphisms with the risk of breast cancer in Egyptian women.
Galal ER; Abdelhakam DA; Ahmed LK; Elhusseny Y; Sayed SEP; Eltaweel NH
Mol Biol Rep; 2024 Apr; 51(1):495. PubMed ID: 38587571
[TBL] [Abstract][Full Text] [Related]
4. CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.
Tulsyan S; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B
PLoS One; 2013; 8(8):e71073. PubMed ID: 23940692
[TBL] [Abstract][Full Text] [Related]
5. [Association of CD44 polymorphisms with genetic susceptibilities and clinico-pathologic characteristics in breast cancer].
Zhou X; Wu CY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):807-11. PubMed ID: 23387202
[TBL] [Abstract][Full Text] [Related]
6. CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.
Jiang L; Deng J; Zhu X; Zheng J; You Y; Li N; Wu H; Lu J; Zhou Y
Breast Cancer Res; 2012 Jul; 14(4):R105. PubMed ID: 22788972
[TBL] [Abstract][Full Text] [Related]
7. Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.
Gallegos-Arreola MP; García Verdín PM; Magaña-Torres MT; Figuera LE; Zúñiga-González GM; Rosales-Reynoso MA; Gómez-Meda BC; Puebla-Pérez AM
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6454-6464. PubMed ID: 34787849
[TBL] [Abstract][Full Text] [Related]
8. Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.
Qiu Y; Hu Y; Zhang ZY; Ye L; Xu FH; Schneider ME; Ma XL; Du YX; Zuo XB; Zhou FS; Chen G; Xie XS; Zhang Y; Xia HZ; Wu JF; Du WD
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2143-56. PubMed ID: 25009318
[TBL] [Abstract][Full Text] [Related]
9. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
10. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
[TBL] [Abstract][Full Text] [Related]
11. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
12. Association of L55M and Q192R polymorphisms in paraoxonase 1 (PON1) gene with breast cancer risk and their clinical significance.
Hussein YM; Gharib AF; Etewa RL; ElSawy WH
Mol Cell Biochem; 2011 May; 351(1-2):117-23. PubMed ID: 21229382
[TBL] [Abstract][Full Text] [Related]
13. Strong Correlation of MTHFR Gene Polymorphisms with Breast Cancer and its Prognostic Clinical Factors among Egyptian Females.
Omran MH; Fotouh BE; Shousha WG; Ismail A; Ibrahim NE; Ramadan SS
Asian Pac J Cancer Prev; 2021 Feb; 22(2):617-626. PubMed ID: 33639682
[TBL] [Abstract][Full Text] [Related]
14.
Verma A; Kapoor R; Mittal RD
Indian J Clin Biochem; 2017 Mar; 32(1):74-83. PubMed ID: 28149016
[TBL] [Abstract][Full Text] [Related]
15. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
Bayram S; Sümbül AT; Dadaş E
Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in lncRNA
Yang H; Sun Q; Chong F; Jiang X; Wang Y; Xu K; Zou Y; Xu L; Song C
Aging (Albany NY); 2021 Nov; 13(21):24360-24378. PubMed ID: 34762068
[TBL] [Abstract][Full Text] [Related]
17. Impact of XRCC1 genetic variants on its tissue expression and breast cancer risk: A case-control study.
Abdel Ghafar MT; El-Rashidy MA; Gharib F; Al-Ashmawy GM
Environ Mol Mutagen; 2021 Aug; 62(7):399-408. PubMed ID: 34331480
[TBL] [Abstract][Full Text] [Related]
18. Association of Single-Nucleotide Polymorphisms of CD44 Gene with Susceptibility to Breast Cancer in Chinese Women.
Lin X; You X; Cao X; Pan S
Med Sci Monit; 2018 May; 24():3077-3083. PubMed ID: 29748526
[TBL] [Abstract][Full Text] [Related]
19. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
20. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand.
Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]